Arcus Biosciences Stock (NYSE:RCUS), Quotes and News Summary

Q: What sector and industry does Arcus Biosciences (RCUS) operate in?

Arcus Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.

Arcus Biosciences Stock (NYSE: RCUS) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 785.802K
Day Range	- - -
52 Wk Range	12.950 - 25.470
Market Cap	$1.410B
P/E Ratio	-
Dividend Yield	-
Exchange	NYSE
RSI	0
Short Interest	18.84%
Days to Cover	11.43

Recent News

$320M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying

Although U.S. stocks closed lower on Wednesday, there were a few notable insider trades.

Avi Kapoor

Pharma Giant Gilead Raises Stake In Cancer-Focused Arcus Biosciences, Stock Soars

Arcus Biosciences sees a 17.1% surge as Gilead Sciences amends collaboration, investing $320M at $21.00/share. Accelerate joint programs in cancer therapy.

Vandana Singh

Positive News For Gastric Cancers - Gilead/Arcus Biosciences' Combination Cancer Therapy Shows Encouraging Clinical Activity

Gilead Sciences Inc (NASDAQ: GILD) and Arcus Biosciences Inc (NYSE: RCUS) announced that domvanalimab plus zimberelimab and chemotherapy showed encouraging overall response rate (ORR) and six-month progress

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Jan

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Arcus Biosciences (RCUS) stock?

You can purchase shares of Arcus Biosciences (NYSE: RCUS) through any online brokerage.

View our list of the best stock brokerages.

Who are Arcus Biosciences's (RCUS) competitors?

Other companies in Arcus Biosciences’s space includes: Gyre Therapeutics (NASDAQ:GYRE), 4D Molecular Therapeutics (NASDAQ:FDMT), Prothena Corp (NASDAQ:PRTA), Day One Biopharmaceutical (NASDAQ:DAWN) and Xencor (NASDAQ:XNCR).

What is the target price for Arcus Biosciences (RCUS) stock?

The latest price target for Arcus Biosciences (NYSE: RCUS) was reported by Truist Securities on Monday, March 25, 2024. The analyst firm set a price target for 50.00 expecting RCUS to rise to within 12 months (a possible 222.58% upside). 19 analyst firms have reported ratings in the last year.

Current Stock Price for Arcus Biosciences (RCUS)?

The stock price for Arcus Biosciences (NYSE: RCUS) is $15.5 last updated May 1, 2024 at 4:20 PM EDT.

Does Arcus Biosciences (RCUS) pay a dividend?

There are no upcoming dividends for Arcus Biosciences.

When is Arcus Biosciences (NYSE:RCUS) reporting earnings?

Arcus Biosciences’s Q1 earnings are confirmed for Wednesday, May 8, 2024.

Is Arcus Biosciences (RCUS) going to split?

There is no upcoming split for Arcus Biosciences.

What sector and industry does Arcus Biosciences (RCUS) operate in?

Arcus Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.

-

-

-

-

-

-

-

-

-

-

-

-

-

-